Product testing, labeling and advertising laws by state

172 bills on product testing, labeling and advertising in 41 jurisdictions, 23 of them enacted in 2025 and 2026. The laws come first, with what each requires, then the bills that moved most recently.

  • 23 laws enacted in 2025 and 2026, in 16 states. Most: California (4), Oklahoma (3), Maryland (2).
  • 172 bills in 41 jurisdictions. Latest action 9 November 2026.

Updated 14 November 2026LawsRecent billsBy state

Enacted in 2025 and 2026

23 laws, by state. Laws enacted before 2025 are not listed.

Arizona

  • Enacted

    HB 2179: marijuana; advertising; restrictions

    Marijuana establishments, nonprofit medical marijuana dispensaries, and marijuana paraphernalia sellers must not advertise to individuals under twenty-one years of age, at public transportation facilities, or with false health claims. All advertising must include a conspicuous warning and meet audience age requirements of at least 73.6 percent adults for electronic and sponsored event advertising.

Arkansas

  • Enacted

    SB 305: To require certain testing of processed marijuana products sold as medical marijuana.

    All processed marijuana products must be tested after being fully processed and in finished form suitable for packaging. Testing must comply with Department of Health rules and include pesticides, heavy metals, microbiological contaminants, residual solvents, and concentrations of tetrahydrocannabinol and cannabidiol.

California

  • Enacted

    AB 2532: Cannabis: labels, packaging, and advertising.

    Persons engaged in commercial cannabis activity must include the national Poison Help line toll-free number on labels and inserts for edible cannabis products and cannabis beverages. Commencing July 1, 2027, retailers must offer consumers a measuring device at no charge for cannabis beverages with multiple servings, and persons engaged in commercial cannabis activity must not advertise cannabis beverages with multiple servings as single-serve products.

    Takes effect 1 January 2027

  • Enacted

    AB 1965: Cannabis: testing: quality assurance.

    Retailers and other licensees authorized to engage in retail sale of cannabis or cannabis products must provide certificates of analysis to customers upon request and allow the department to obtain or access products for off-the-shelf laboratory testing. Testing laboratories must be subject to performance testing to ensure consistency of results across laboratories.

    Takes effect 1 January 2027

  • Enacted

    AB 2249: Cannabis: labels, packaging, and advertising.

    Commencing January 1, 2028, cannabis and cannabis product packaging and labeling must not be attractive to children, defined as designed or likely to appeal to individuals under 21 years of age. Prohibited elements include cartoons, depictions of minors, child-associated celebrities or characters, magical creatures, child-marketed consumables, childlike typography, and candy-related terms. Edible cannabis and vape cartridge labeling must not include cartoon or overly stylized fruit depictions.

    Takes effect 1 January 2027

  • Enacted

    AB 8: Cannabis: cannabinoids: industrial hemp.

    Beginning January 1, 2026, industrial hemp raw extract incorporated into food, beverages, or dietary supplements must have purity greater than 99 percent and contain no THC or synthetic cannabinoids. Persons engaged in selling cigarettes or tobacco products must not possess, store, own, or retail cannabis or cannabis products at those locations.

    Took effect 1 January 2026

Connecticut

  • Enacted

    HB 7181: An act concerning the regulation of tobacco, cannabis, hemp and related products, conduct and establishments.

    Persons selling cigarettes or taxed tobacco products at retail must secure a dealer's license from the Commissioner of Revenue Services. Applicants must provide notice to the municipality clerk and post notice at the business location. Dealers must maintain records and verify age of customers entering locations deriving at least fifty percent of annual revenue from tobacco and related products.

    Took effect 1 October 2025

Georgia

  • Enacted

    SB 33: "Georgia Hemp Farming Act"; total THC concentration of consumable hemp products; provide limits

    Processors and manufacturers of consumable hemp products must ensure such products do not exceed 0.3 percent total concentration of intoxicating cannabinoids on a dry weight basis. They must contract for a full panel certificate of analysis within the last 12 months and make it available to the public. Products must bear a THC warning sticker and label with analysis information or QR code access.

Maine

  • Enacted

    LD 1488: An Act Regarding Cannabis Testing And The Manufacture Of Cannabis And Hemp Products

    Amends cannabis testing requirements to exclude retesting when cannabis or cannabis products have not undergone further processing, manufacturing, or alteration that would increase contaminant concentration, with an exception for edible cannabis products made from cannabis concentrate.

Maryland

  • Enacted

    SB 594: Cannabis - Advertising - Alterations

    Cannabis licensees must not advertise in ways that target individuals under 21 years old or use designs attractive to minors. Standard dispensary license holders may place exterior signage identifying the business and providing contact information, subject to size limits of 900 square inches per sign or 1,200 square inches total. The Maryland Cannabis Administration must accept audience composition data and establish a process for event sponsorship attestations by January 1, 2027.

    Took effect 1 July 2026

  • Enacted

    SB 820: Alcohol, Tobacco, and Cannabis Commission - Unauthorized Consumable Products - Enforcement and Seizure

    Retailers may not distribute, sell, expose for sale, or advertise for sale unauthorized consumable products, which include tianeptine products, certain kratom products not complying with labeling requirements, certain phenibut products not complying with labeling requirements, and consumable products containing poisonous or deleterious substances designated by the Secretary of Health. The Maryland Department of Health must notify the Alcohol, Tobacco, and Cannabis Commission within 30 days after changes to regulatory or approval status of these products.

    Took effect 1 July 2026

Michigan

  • Enacted

    SB 433: State agencies (existing): health and human services; educational materials regarding health dangers for youth using high-potency THC and cannabis products; require the department to provide. Amends 1976 PA 451 (MCL 380.1 - 380.1852) by adding sec. 1509.

    The department of health and human services must develop an informational notice by July 1, 2026, in English, Spanish, and Arabic containing information on dangers of tobacco, vapor, alternative nicotine, THC cannabis, and synthetic intoxicating hemp products, plus resources and THC poisoning recognition. School boards and nonpublic school governing bodies must provide this notice to parents by October 1 annually and post a link on their websites.

Minnesota

  • Enacted

    HF 3615: Cannabis laboratory testing requirements extended.

    Cannabis businesses and hemp businesses must not sell, offer for sale, or transfer cannabis flower, cannabis products, artificially derived cannabinoids, lower-potency hemp edibles, or hemp-derived consumer products unless a representative sample has been tested by a licensed cannabis testing facility or qualifying laboratory and meets established testing standards.

Montana

  • Enacted

    HB 792: Generally revise laws related to cannabis labeling and education

    Manufacturers, packagers, sellers, and transferors of marijuana and marijuana products must display warning labels on packages with specified text in legible font and include a universal warning symbol. Marijuana businesses must display consumer education posters at points of sale that are at least 8.5 by 11 inches and include warning text, a universal symbol, and contact information for addiction assistance resources.

Nevada

  • Enacted

    AB 504: Establishes certain deceptive trade practices relating to the sale of or an offer to sell certain hemp products. (BDR 56-867)

    A person who does not hold a cannabis establishment license and sells or offers to sell hemp products intended for human consumption must display signs at each customer entrance stating the location is not licensed to sell cannabis and at each sales station stating all hemp products contain less than the legal limit of THC. Such persons must not advertise false, misleading, or deceptive statements about their licensing status or the nature of hemp products.

  • Enacted

    SB 157: Revises provisions relating to the testing of cannabis and cannabis products. (BDR 56-962)

    The Cannabis Compliance Board shall adopt regulations requiring licensees and registrants to have representative samples of each lot of cannabis tested by a cannabis independent testing laboratory. Sample collection must align with ASTM D8334/8334M standards. For cannabis flower lots, aggregate sample weights must be at least 10 grams for lots under 5 pounds, 15 grams for 5-10 pounds, and 20 grams for 10-15 pounds.

North Dakota

  • Enacted

    HB 1203: AN ACT to create and enact section 19-24.1-24.1 and a new subsection to section 19-24.1-36 of the North Dakota Century Code, relating to regulating edible medical marijuana products; and to amend and reenact section 19-24.1-01 of the North Dakota Century Code, relating to definitions of medical marijuana products.

    Manufacturing facilities must obtain prior department approval before manufacturing cannabinoid edible products. Dispensaries must obtain prior department approval before possessing, marketing, or selling cannabinoid edible products. The department must review and approve the form, manufacturing, packaging, labeling, and marketing of each cannabinoid edible product before approval.

Oklahoma

  • Enacted

    HB 4454: Medical marijuana; providing certain restrictions on edible products; effective date.

    Licensed medical marijuana processors must ensure edible products do not appeal to children through cartoons, toys, animals, or similar imagery, are not shaped like humans or animals, and do not resemble commercially available candy. Packages must clearly indicate servings and tetrahydrocannabinol content per serving.

    Took effect 1 November 2026

  • Enacted

    SB 518: Medical marijuana packaging; requiring certain warnings on labels. Effective date.

    Medical marijuana businesses must package and label medical marijuana products to minimize appeal to children, avoid false or misleading statements, and include specific warnings: "For use by licensed medical marijuana patients only", "Keep out of reach of children", warnings about driving and pregnancy, and a statement that the product has been tested for contaminants.

    Took effect 1 November 2025

  • Enacted

    SB 774: Medical marijuana licenses; modifying certain identification number; requiring certain barcode. Effective date.

    The Oklahoma Medical Marijuana Authority must validate medical marijuana patient licenses by a twelve-character identification number and PDF417 barcode through its website and telephone verification system. Licensed dispensaries must verify patient or caregiver licenses using the twelve-character identifier and PDF417 barcode.

    Took effect 1 November 2025

Oregon

  • Enacted

    HB 3724: Relating to cannabis; and prescribing an effective date.

    The Oregon Liquor and Cannabis Commission must adopt rules establishing packaging standards for marijuana items, cannabinoid products, and cannabinoid concentrates and extracts that prevent minors from unlawfully possessing or consuming them, using objective criteria including prohibitions on imagery or characters primarily associated with minors.

Tennessee

  • Enacted

    SB 1761: Agriculture - As enacted, makes various changes relative to the regulation of hemp-derived cannabinoid products. - Amends TCA Title 1, Chapter 3; Title 39; Title 43, Chapter 27; Title 53; Title 57, Chapter 7 and Title 67, Chapter 6.

    Amends Tennessee Code Annotated Section 43-27-102(c) to extend a five-year period to ten years, effective upon enactment. The specific application of this change is not evident from the text provided.

Washington

  • Enacted

    SB 5206: Concerning cannabis retailer advertising.

    Licensed cannabis producers, processors, researchers, and retailers must not place advertisements within one thousand feet of school grounds, playgrounds, recreation centers, child care centers, public parks, libraries, or game arcades allowing persons under 21. Retailers may display only four signs affixed to their building or hanging in windows, each no larger than one thousand six hundred square inches. All cannabis advertising must include text stating only persons 21 years or older may purchase or possess cannabis products.

    Took effect 1 January 2026

Bills that moved most recently

The 25 open product testing, labeling and advertising bills with the latest action. The Cannabis Legislation Tracker follows all 172.

  • Texas SB 237: Relating to regulating the cultivation, manufacture, processing, distribution, sale, testing, transportation, delivery, transfer, possession, and use of cannabis and cannabis products; authorizing the imposition of fees; requiring occupational licenses; creating a criminal offense.

    What it would do: Creates a regulatory framework for cannabis cultivation, manufacturing, processing, distribution, sale, testing, and possession by adults 21 and older in Texas, establishing licensing requirements for growers, establishments, secure transporters, and testing facilities, and authorizing local elections to permit operations.

    Introduced

  • Pennsylvania SB 120: An Act providing for cannabis; regulating the personal use and possession of cannabis; establishing the Cannabis Control Board; providing for powers and duties of the Cannabis Control Board; establishing the Cannabis Regulation Fund; providing for disproportionately impacted area, for regulation of cannabis business establishments, for enforcement and immunities, for laboratory testing, for advertising, marketing, packaging and labeling and for preparation, destruction and regulation of cannabis, edible and infused products; imposing a sales tax and excise tax on cannabis, edible and infused products; establishing the Cannabis Regulation Fund; providing for cannabis clean slate and for miscellaneous provisions; imposing penalties; consolidating provisions relating to medical use of cannabis; transferring powers and duties of the Department of Health to the Cannabis Control Board; and making repeals.

    What it would do: Establishes a Cannabis Control Board to regulate adult-use and medical cannabis in Pennsylvania. Permits individuals 21+ to possess cannabis, creates licensing for dispensaries and cultivation centers, imposes sales and excise taxes, and consolidates medical cannabis regulations under the new board.

    In committee

  • Montana LC 565: Provide one-time funding and statutory authority to allow state grain lab to test marijuana flower

    Introduced

  • New Jersey A 5463: Requires cannabis retailer to display notice of risks of high potency cannabis.

    What it would do: Requires the Cannabis Regulatory Commission to develop a notice about health risks of high potency cannabis, including risks for individuals under 25 and those with mental health conditions, and mandates cannabis retailers conspicuously display this notice at the point of sale.

    In committee

  • New Jersey A 5476: Requires training for employees in certain settings to recognize and respond to indications of intoxication in children from consumption of cannabis item.

    What it would do: Requires the Commissioners of Education, Children and Families, and Health to develop training programs within 180 days for school employees, child care center staff, and youth program employees to recognize and respond to cannabis intoxication in children.

    In committee

  • Puerto Rico PC 223: Para enmendar el Artículo 6(j) de la Ley Núm. 5 de 23 de abril de 1973, según enmendada, conocida como “Ley Orgánica del Departamento de Asuntos del Consumidor” a los fines de conceder expresamente al Departamento de Asuntos del Consumidor la facultad de reglamentar y fiscalizar los anuncios, ofertas y ventas de productos con cannabidiol (CBD) o relacionados al cannabis medicinal, en comercios que no son dispensarios autorizados bajo la Ley Núm. 42-2017, según enmendada, conocida como “Ley para Manejar el Estudio, Desarrollo e Investigación del Cannabis para la Innovación, Normas Aplicables y Límites”; autorizar la aprobación de reglamentos; y para otros fines relacionados.

    What it would do: Amends the Organic Law of the Department of Consumer Affairs to grant the Department authority to regulate and oversee advertisements, offers, and sales of cannabidiol (CBD) and medical cannabis products in non-authorized dispensaries.

    Passed chamber

  • California AB 1826: Cannabis: recall, embargo, and destruction of cannabis and cannabis products.

    What it would do: Revises cannabis recall, embargo, and destruction procedures by requiring the Department of Cannabis Control to provide licensees with evidence supporting adulteration or misbranding findings, offer informal conferences before voluntary recalls and embargoes, and prohibit requiring waivers of rights as conditions for department actions.

    Passed chamber

  • New York A 11606: Prohibits copycat cannabis products

    What it would do: Prohibits any person or entity from manufacturing, selling, or possessing cannabis products with packaging or labeling substantially similar to or likely to create confusion with non-cannabis products. Requires the cannabis board to promulgate implementing rules.

    In committee

  • New York S 5827: Requires all edible cannabis products be packaged in child resistant packaging

    What it would do: Prohibits registered organizations, licensees, permittees, and other entities under the board's jurisdiction from selling or delivering edible cannabis products in New York unless they are packaged in child resistant packaging. Takes effect 180 days after becoming law.

    In committee

  • New York A 9622: Relates to limiting prohibitions of advertising of cannabis products or services on billboards

    What it would do: Amends cannabis law to permit billboards advertising licensed cannabis businesses with specified information only, while prohibiting such billboards in cities with populations of one million or more.

    In committee

  • New York S 8913: Limits prohibitions of advertising of cannabis products or services on billboards

    What it would do: Permits billboards advertising cannabis licensees to include specified business information like name, address, hours, and social equity status, while prohibiting such billboards in cities with populations of one million or more.

    In committee

  • Missouri HJR 103: Proposes a constitutional amendment relating to the advertising and promotion of marijuana sales

    What it would do: Proposes a constitutional amendment repealing and replacing Sections 1 and 2 of Article XIV to regulate medical marijuana sales, establish licensing for cultivation and dispensary facilities, impose a 4% retail tax on medical marijuana sales, and provide expungement for certain prior marijuana convictions.

    In committee

  • New Jersey S 4148: Establishes maximum THC potency of cannabis items and imposes excise tax of moderate and high potency cannabis items.

    What it would do: Establishes a maximum THC potency of 60 percent for cannabis items and imposes excise taxes of $1 per serving for moderate THC items (15-40 percent potency) and $5 per serving for high THC items (over 40 percent potency).

    In committee

  • Massachusetts H 167: An Act to create a competitive cannabis testing program

    In committee

  • Massachusetts H 187: An Act relative to cannabis marketing

    In committee

  • Massachusetts H 188: An Act relative to cannabis advertisements by out of state dispensaries

    In committee

  • Massachusetts H 189: An Act relative to billboard advertisements for cannabis

    In committee

  • Massachusetts H 191: An Act relative to limiting the potency of THC products

    In committee

  • Massachusetts H 193: An Act to improve warning labels on THC products

    In committee

  • New York A 8820: Authorizes the office of cannabis management and cannabis control board establish a track and trace program

    What it would do: Authorizes the office of cannabis management and cannabis control board to implement a track and trace program using unique package identifiers at the case level, and prohibits the board from requiring licensees to track individual product units beyond the package level.

    In committee

  • Illinois HB 4501: Cannabis-accidental ingestion

    What it would do: Requires dispensing organizations to include locked storage bag information in purchaser education, display placards stating cannabis should be kept away from children in locked containers, stock lockable opaque storage containers for sale, and add Illinois Poison Center phone number warnings to cannabis-infused product labels.

    In committee

  • Minnesota HF 4733: Remediated cannabis product defined, and cannabis business required to disclose information related to remediated cannabis products.

    What it would do: Defines remediated cannabis products and requires licensed cannabis businesses to conspicuously display a specific statement on product labels and in all marketing materials. Establishes civil penalties of at least $1,000 for first violations and $5,000 for second violations within three years, with license suspension or revocation for three violations in five years.

    In committee

  • Connecticut SB 231: An act concerning the department of consumer protection's recommendations regarding cannabis regulation and electronic nicotine delivery system dealer registration.

    What it would do: Requires cannabis establishments to submit samples for testing and dispose of failed batches within 60 days. Expands grounds for denying electronic nicotine delivery system dealer registrations to include criminal background checks and multiple violations by owners or related entities.

    Passed committee

  • Minnesota HF 4688: Cannabis license holders allowed to transport products to testing facilities.

    What it would do: Allows cannabis microbusiness, mezzobusiness, cultivator, and manufacturer license holders to transport cannabis products and hemp-derived consumer products to cannabis testing facilities for testing purposes.

    In committee

  • New Mexico HB 294: Cannabis product packaging regulations

    What it would do: Regulates cannabis product packaging and labeling to prohibit colors, cartoons, and design elements appealing to minors or mimicking products marketed to children. Deems cannabis products adulterated if they contain artificial color additives not expressly approved by the division, effective January 1, 2027.

    Passed committee

Questions

Which states have product testing, labeling and advertising laws?

States that enacted product testing, labeling and advertising laws in 2025 and 2026: California (4), Oklahoma (3), Maryland (2), Nevada (2), Arizona (1), Arkansas (1), Connecticut (1), Georgia (1), Maine (1), Michigan (1), Minnesota (1), Montana (1), North Dakota (1), Oregon (1), Tennessee (1) and Washington (1). Laws enacted before 2025 are not listed here.

Which states have the most product testing, labeling and advertising bills?

Massachusetts (18), New York (17), New Jersey (10), Maine (9) and Connecticut (8). In all, 172 bills in 41 jurisdictions, the latest action on 9 November 2026.

What do product testing, labeling and advertising bills cover?

Potency limits, laboratory testing, packaging, labeling, flavors and advertising restrictions for cannabis products. Each enacted law above has a line on what it requires.

Is this legal advice?

No. Which bills count as product testing, labeling and advertising bills, and the line on what each law requires or each bill would do, are drafted by software and not reviewed by an attorney. Every bill links to the legislature’s own record: read the text before relying on it. The list covers bills from the 2025 and 2026 sessions.

Follow product testing, labeling and advertising bills in every state

The Cannabis Legislation Tracker sends the bills that moved and a monthly report you can forward to a client.